TICKERNERD
Menu
TRNSTRNSIndustrials · Specialty Business Services

TRNS Stock Forecast: Transcat, Inc. Price Predictions for 2026-2027

Last close, 15 Sept 2026
$81
−1.44% on the day

The 4 Wall Street analysts covering Transcat, Inc. hold a median 12-month price target of $105 — +29.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 53 of 100 as at 15 Sept 2026 — in the upper half.

Market cap
$789.1M
Ticker Nerd rank
53 / 100
Median analyst target
$105
Analysts covering
4
Revenue$92.9M+21.6% y/y
Operating income$3.7M
Net income$1.3M
Free cash flow$4.8M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−3.3%
1M
−13.6%
YTD
+42.8%
1Y
+10.8%
From 52W high
−17.1%
From 52W low
+55.6%
$52
$98
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

TRNS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Transcat, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Sept 2026
53 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
77
Momentum
64
Quality
58
Growth
57
Accruals
50
Size
48
Volatility
47
Value
42
Issuance
19

Revisions (77): Analysts have, on balance, been raising their forecasts.

Issuance (19): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

TRNS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on TRNS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$40$60$80$100$120Oct 25Jan 26Apr 26Jul 26TRNSHigh $113Median $105Low $95

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says4 analysts
2 Buy2 Hold0 Sell
Low $95Median $105High $113

The green dot is the last close — the median target sits +29.6% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
26 Aug 2025HC Wainwright & Co.ReiteratesBuy$116
26 Aug 2025HC Wainwright & Co.ReiteratesBuy—
22 Aug 2025HC Wainwright & Co.ReiteratesBuy$116
22 Aug 2025HC Wainwright & Co.ReiteratesBuy—
10 July 2025Lake StreetInitiatesBuy—
25 June 2025HC Wainwright & Co.ReiteratesBuy—
21 May 2025HC Wainwright & Co.MaintainsBuy—
29 Jan 2025HC Wainwright & Co.MaintainsBuy—
29 Jan 2025Northland Capital MarketsReiteratesMarket Perform—
29 Jan 2025OppenheimerDowngradePerform—
12 Dec 2024Craig-HallumMaintainsBuy—
30 Oct 2024Craig-HallumMaintainsBuy—
30 Oct 2024HC Wainwright & Co.MaintainsBuy—
30 Oct 2024Northland Capital MarketsMaintainsMarket Perform—
30 Oct 2024OppenheimerReiteratesOutperform—
29 Oct 2024HC Wainwright & Co.ReiteratesBuy—
31 July 2024Craig-HallumMaintainsBuy—
31 July 2024HC Wainwright & Co.ReiteratesBuy—
30 July 2024HC Wainwright & Co.ReiteratesBuy—
22 May 2024HC Wainwright & Co.MaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. TRNS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

TRNS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 15 Sept 2026, Transcat, Inc. returned +10.8% against +15.9% for the S&P 500, dividends included.

TRNS vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120130Oct 25Jan 26Apr 26Jul 26TRNSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

TRNS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−7.7%
Analysts raising
3
Analysts cutting
1
Fundamentals

Transcat, Inc. (TRNS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
228.0×

Cheaper than 3% of US stocks

Price / sales
2.2×

Cheaper than 50% of US stocks

Price / book
2.5×

Cheaper than 37% of US stocks

EV / EBITDA
21.5×

Cheaper than 14% of US stocks

Growth & margins
Revenue growth (YoY)
21.6%

Higher than 71% of US stocks

Earnings growth (YoY)
−59.2%

Higher than 8% of US stocks

Gross margin
33.1%

Higher than 39% of US stocks

Operating margin
5.5%

Higher than 56% of US stocks

Net margin
1.0%

Higher than 50% of US stocks

Returns & dividend
Return on equity
1.2%

Higher than 46% of US stocks

Return on assets
2.2%

Higher than 60% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Transcat, Inc. (TRNS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Transcat, Inc. has a market value of $789.1M and an enterprise value of $925.7M.

  • Revenue in the twelve months to 30 June 2026: $348.4M. The latest quarter grew 21.6% year on year.

  • Net income over the same four quarters: $3.4M, a 1.0% net margin.

  • Diluted earnings per share, trailing twelve months: $0.37.

  • Free cash flow in the twelve months to 30 June 2026: $25.4M.

  • Transcat, Inc. spent $2.3M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 9.4M.

  • Trailing P/E: 228.0×; forward P/E: 37.9× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Transcat, Inc. employs 1,413 people — $247K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Sept 2026

Data provided by Twelve Data

Peers

TRNS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Business Services
CompanyMarket capTKN rank
TRNSTranscat, Inc.$789.1M
53
BUUUBUUU Group Ltd.$727.0M
2
CASSCass Information Systems, Inc.$726.6M
79
BKSYBlacksky Technology, Inc.$874.9M
17
KODKEastman Kodak Co.$885.9M
74
RHLDResolute Holdings Management, Inc.$965.3M
7
BVBrightView Holdings, Inc.$1.0B
41

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Transcat, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest TRNS news & analysis

Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point

Seeking Alpha · 16 Sept 2026positive

The article gives Transcat a BUY rating, citing its mission-critical calibration services business and recent share price weakness as a solid entry point. It notes robust Q1 FY27 results with revenue up 22% YoY, service segment operating income up 35% YoY, and organic service growth of 13% YoY, while the stock trades at a discount to its recent EV/EBITDA peak.

Why it matters — A TRNS watcher would care because the piece highlights the company's strong recurring revenue, operating leverage, and the valuation opportunity presented by the recent share price decline.

Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

Business Wire · 31 Aug 2026positive

Transcat, Inc. announced that it has expanded its biomedical calibration channel through the acquisition of Southeastern Biomedical. The transaction was disclosed via a Business Wire release from Rochester, N.Y.

Why it matters — This acquisition broadens Transcat's biomedical calibration capabilities and channel reach, which could strengthen its service offering for TRNS watchers.

Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript

Seeking Alpha · 5 Aug 2026neutral

Seeking Alpha published the transcript of Transcat, Inc.'s (TRNS) Q1 2027 earnings call, covering the company's first-quarter fiscal 2027 results discussion. The excerpt provided only contains the transcript's title and source information without details from the call.

Why it matters — A TRNS watcher would care because the earnings call transcript offers insight into the company's latest quarterly performance and management's commentary for the fiscal year.

Transcat Q1 Earnings Call Highlights

MarketBeat · 5 Aug 2026positive

Transcat reported fiscal 2027 first-quarter revenue of $92.9 million, a 22% year-over-year increase, with both its calibration services and distribution segments achieving double-digit growth.

Why it matters — The broad-based revenue growth across key regulated end markets signals continued strong demand for Transcat's services.

FAQ

Frequently asked questions about TRNS stock

What is the TRNS stock price forecast for 2026-2027?

The 4 Wall Street analysts covering Transcat, Inc. have a median 12-month price target of $105, with estimates ranging from $95 to $113. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is TRNS stock a buy right now?

Of the 4 analysts covering Transcat, Inc., 2 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Transcat, Inc. 53 out of 100 across roughly 4,600 US stocks as at 15 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank TRNS?

As at 15 Sept 2026, Transcat, Inc. ranks 53 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (77 of 100).

Will TRNS stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +29.6% from the last close, and Ticker Nerd's factor model ranks Transcat, Inc. 53 out of 100 as at 15 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the TRNS stock forecast for 2030?

No analyst covering Transcat, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TRNS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $95 to $113 over the next 12 months.

How has TRNS stock performed over the past year?

Transcat, Inc. returned +10.8% over the 12 months to 15 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Transcat, Inc. do?

Transcat Inc. is a calibration and laboratory instrument services company that supports organizations requiring precise measurement, testing, and compliance capabilities.

What is the latest news on TRNS?

The most recent item we track (Seeking Alpha, 16 Sept 2026): "Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point". The article gives Transcat a BUY rating, citing its mission-critical calibration services business and recent share price weakness as a solid entry point. It notes robust Q1 FY27 results with revenue up 22% YoY, service segment operating income up 35% YoY, and organic service growth of 13% YoY, while the stock trades at a discount to its recent EV/EBITDA peak.

Company

About Transcat, Inc.

Transcat Inc. is a calibration and laboratory instrument services company that supports organizations requiring precise measurement, testing, and compliance capabilities. Its core business is centered on accredited calibration, repair, inspection, preventive maintenance, and related technical services, delivered through a Service segment that serves highly regulated industries such as life sciences, aerospace, defense, energy, utilities, and manufacturing. Transcat also operates a Distribution segment that supplies professional test, measurement, and control instrumentation, along with rental and other equipment-related offerings. The company’s services help customers maintain instrument accuracy, meet regulatory requirements, and support quality assurance across laboratory and industrial environments. With operations in the United States, Canada, and international markets, Transcat plays a specialized role in the broader industrial technology and metrology ecosystem by combining service expertise with equipment distribution.

CEO Mr. Jaime A. Irick · 1,413 employees · United States · https://www.transcat.com